Identification of a predictive phosphoproteomic signature of response to atezolizumab and bevacizumab (AB) in patients with advanced hepatocellular carcinoma (aHCC)

被引：0
|
作者：
Sarker, Debashis
Borek, Weronika E.
Pedicona, Federico
Zen, Yoh
Christopher, Josie A.
Karampera, Christina
Campbell, Amy
Khorsandi, Shirin Elizabeth
Dowe, Thomas
Habarwaa, Marwo
Britton, David James
Heaton, Nigel
Cutillas, Pedro Rodriguez
Williamson, Andrew
Dokal, Arran David
机构：
[1] Kings Coll Hosp London, Inst Liver Studies, London, England
[2] Kinomica Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2631
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab- bevacizumab
    Campani, Claudia
    Vallot, Ariane
    Ghannouchi, Haroun
    Allaire, Manon
    Evain, Manon
    Sultanik, Philippe
    Sidali, Sabrina
    Blaise, Lorraine
    Thabut, Dominique
    Nahon, Pierre
    Seror, Olivier
    Ganne-Carrie, Nathalie
    Nault, Jean-Charles
    Wagner, Mathilde
    Sutter, Olivier
    HEPATOLOGY, 2024, 79 (01) : 49 - 60
  • [42] Atezolizumab and bevacizumab in the treatment of advanced hepatocellular carcinoma - a single-center experience
    Adzic, G.
    Prejac, J.
    Librenjak, N.
    Kekez, D.
    Gorsic, I.
    Plestina, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S115 - S115
  • [43] Pretreatment eosinophil count predicts response to atezolizumab plus bevacizumab therapy in patients with hepatocellular carcinoma
    Toshida, Katsuya
    Itoh, Shinji
    Yoshiya, Shohei
    Nagao, Yoshihiro
    Tomino, Takahiro
    Izumi, Takuma
    Iseda, Norifumi
    Toshima, Takeo
    Ninomiya, Mizuki
    Yoshizumi, Tomoharu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (03) : 576 - 586
  • [44] A MACHINE LEARNING MODEL TO PREDICT THE TREATMENT RESPONSE OF ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Hur, Moon Haeng
    Kim, Bo Hyun
    Song, Byeong Geun
    Sinn, Dong Hyun
    Shin, Hyunjae
    Cho, Yuri
    Park, Youngsu
    Park, Jeayeon
    Ko, Yunmi
    Lee, Yun Bin
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    HEPATOLOGY, 2024, 80
  • [45] Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
    Maesaka, Kazuki
    Sakamori, Ryotaro
    Yamada, Ryoko
    Doi, Akira
    Tahata, Yuki
    Ohkawa, Kazuyoshi
    Oshita, Masahide
    Miyazaki, Masanori
    Yakushijin, Takayuki
    Nozaki, Yasutoshi
    Matsumoto, Kengo
    Tanaka, Satoshi
    Kaneko, Akira
    Iio, Sadaharu
    Nawa, Takatoshi
    Yamada, Yukinori
    Morishita, Naoki
    Usui, Takeo
    Hiramatsu, Naoki
    Doi, Yoshinori
    Sakakibara, Mitsuru
    Imanaka, Kazuho
    Yoshida, Yuichi
    Kodama, Takahiro
    Hikita, Hayato
    Tatsumi, Tomohide
    Takehara, Tetsuo
    PLOS ONE, 2023, 18 (02):
  • [46] The impact of previous local therapy (LT) on overall survival (OS) in patients with advanced hepatocellular carcinoma (aHCC) treated with atezolizumab/bevacizumab (A plus B) as first line systemic therapy
    Fierro, Maria Elena
    Alkadimi, Munaf
    Boyle, Lauren Diaz
    Lucero, Kana
    Mader, Michael
    Franklin, Kathleen
    Nooruddin, Zohra
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Regorafenib for patients with progression of advanced hepatocellular carcinoma after treatment with atezolizumab plus bevacizumab: a case series
    Kang, Wendi
    Fu, Hongjiang
    Luo, Yingen
    Noreika, Danielle M.
    Cong, Tianhao
    Li, Hang
    Yang, Zhengqiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 780 - 787
  • [48] ANALYSIS OF FACTORS PREDICTING THE REAL-WORLD EFFICACY OF ATEZOLIZUMAB AND BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Ha, Chang Won
    Paik, Yong-Han
    Song, Byeong Geun
    HEPATOLOGY, 2024, 80
  • [49] Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma
    Hwang, Sang Youn
    Woo, Hyun Young
    Heo, Jeong
    Kim, Hyung Jun
    Park, Young Joo
    Yi, Ki Youn
    Lee, Yu Rim
    Park, Soo Young
    Chung, Woo Jin
    Jang, Byoung Kuk
    Tak, Won Young
    CANCERS, 2024, 16 (04)
  • [50] Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma
    Song, Byeong Geun
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Yong-Han
    GUT AND LIVER, 2024, 18 (04) : 709 - 718
12345